WO1997019083A1 - Process for extracting and purifying morphine from opium - Google Patents
Process for extracting and purifying morphine from opium Download PDFInfo
- Publication number
- WO1997019083A1 WO1997019083A1 PCT/US1996/018793 US9618793W WO9719083A1 WO 1997019083 A1 WO1997019083 A1 WO 1997019083A1 US 9618793 W US9618793 W US 9618793W WO 9719083 A1 WO9719083 A1 WO 9719083A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- basic
- solution
- methanol
- extracting
- alcohol
- Prior art date
Links
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 title claims abstract description 85
- 238000000034 method Methods 0.000 title claims abstract description 41
- 229960005181 morphine Drugs 0.000 title claims abstract description 41
- 239000008896 Opium Substances 0.000 title claims abstract description 33
- 229960001027 opium Drugs 0.000 title claims abstract description 33
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000007864 aqueous solution Substances 0.000 claims abstract description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 238000000605 extraction Methods 0.000 claims abstract description 27
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000243 solution Substances 0.000 claims abstract description 22
- 239000000706 filtrate Substances 0.000 claims abstract description 21
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 8
- 239000000839 emulsion Substances 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 69
- 239000002904 solvent Substances 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 239000003637 basic solution Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000001632 sodium acetate Substances 0.000 claims description 6
- 235000017281 sodium acetate Nutrition 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims description 4
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 4
- 239000013618 particulate matter Substances 0.000 claims description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 claims description 4
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- 239000011236 particulate material Substances 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000008096 xylene Substances 0.000 claims description 3
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 claims description 2
- 235000011056 potassium acetate Nutrition 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 239000011343 solid material Substances 0.000 claims description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims 2
- 238000003808 methanol extraction Methods 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000001476 alcoholic effect Effects 0.000 abstract description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 229930013930 alkaloid Natural products 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 239000000284 extract Substances 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 9
- 238000011084 recovery Methods 0.000 description 8
- 239000006286 aqueous extract Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 4
- -1 methanol at pH 9 Chemical compound 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 239000000401 methanolic extract Substances 0.000 description 3
- 229930013053 morphinan alkaloid Natural products 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229960004126 codeine Drugs 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000002152 aqueous-organic solution Substances 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
Definitions
- This invention relates to an improved process for the extraction and purification of morphine from opium.
- the object of this invention is to provide a more economical method of preparing morphine that utilizes less environmentally toxic solvents.
- Morphine is useful as an analgesic drug. It is also used as the starting material for the preparation of codeine, which is another analgesic and antitussive drug. Morphine occurs naturally in opium to the extent of 9 to 17% by weight, depending upon the opium source.
- the present invention relates to a process for extracting morphine from opium.
- the process of the invention answers the deficiencies of prior art processes.
- opium is extracted with a basic alcoholic solution.
- the basic alcoholic solution is filtered and the alcohol removed from the filtrate to leave a residue.
- the residue is then extracted with a basic aqueous solution having a pH of at least 1 1 .
- the basic aqueous solution may be filtered to remove any solid matter remaining after the aqueous extraction step, and may then be stirred with a sufficicnl amount of a salt to avoid emulsion formation.
- the basic aqueous solution is then extracted with a substantially water-immiscible solvent such as benzene or toluene.
- adjusting the pH of the basic aqueous solution to pH 8.5 to 9.5 allows the morphine to precipitate and be recovered.
- Figure 1 depicts a preferred process according to the invention for extracting and purifying morphine from opium.
- morphine is extracted from opium by stirring and/or heating, or preferably refluxing, opium in a basic solution of an alcohol, preferably methanol at about pH 9.
- the pH may be adjusted by the addition of an inorganic base (alkali hydroxide, or carbonate), ammonia, and the like.
- inorganic bases include, but are not limited to, sodium hydroxide and potassium hydroxide.
- the resulting residue, which contains the alkaloids, is mixed or extracted with an basic aqueous solution having a pH of at least 1 1 , preferably an aqueous solution of an alkali hydroxide.
- an basic aqueous solution having a pH of at least 1 1 preferably an aqueous solution of an alkali hydroxide.
- This converts the morphine free base present into its anionic (morphinatc) fo ⁇ n which is soluble in basic solutions at pH values of 1 1 or above.
- Other opium alkaloids are relatively insoluble and, in general, at least partially precipitate out ofthe basic aqueous solution.
- the remaining alkaloids are separated from the morphine- containing basic aqueous solution by extraction with a substantially water-immiscible solvent, such as toluene or benzene.
- the morphine free base is precipitated out ofthe resulting aqueous solution by adjusting the pll of the aqueous filtrate to pll 8.5 to 9.5.
- the pH to precipitate the morphine ranges from about 9 to 9.3, and most preferably is about 9.1. This is accomplished by adding either an organic acid or a mineral acid. The yield and purity of morphine produced by this procedure are economically satisfactory.
- the morphine obtained from this process may then be further purified by known methods or utilized directly in a further process to convert it into codeine.
- the extraction of morphine from opium may be accomplished by stirring and/or heating, preferably refluxing, opium with a basic solution of an alcohol capable dissolving morphine in its neutral, cationic, and/or anionic form.
- the alcohol is a C r C 6 alcohol.
- Particularly preferred alcohols include methanol, ethanol, and isopropanol. Mixtures of alcohols may also be used.
- Methanol the preferred solvent for the invention, is a excellent solvent for extracting alkaloids from opium. Almost all of the alkaloids, especially morphine, are highly soluble in methanol.
- the alkaloids are soluble in methanol in their neutral, cationic, or anionic forms.
- an alkali, alkaline earth, or other suitable base to adjust the pH of the alcohol, to about 9, makes the extraction process more efficient. This results in more alkaloids and less impurities being extracted into the alcohol.
- Refluxing opium in a basic solution of the alcohol, preferably methanol at about pH 9, for approximately one to two hours extracts more than 90% of the morphine present.
- 5 g of opium, cut into small pieces may be extracted by reflux with 0.2 to 0.6 g, preferably 0.4 g, of sodium hydroxide in 25 ml of methanol for 1 to 2 hrs.
- An additional extraction of the opium with a basic alcohol, such as methanol at pH 9, can recover essentially all of the alkaloids from opium.
- the second extract can either be combined with the first extract or can be used lo extract another batch of opium. Separation ofthe alcohol extract from the undissolved residue by filtration or other similar means is generally easy and fast. Unlike an aqueous extraction process, the assistance of filter aid at this step is generally unnecessary.
- aqueous extracts or organic solutions e.g. toluene
- a small amount of filter aid may be added to the alcohol extract before distillation to prevent the alcohol extract from foaming and bumping.
- the recovered alcohol particularly methanol. can be recycled and used for another extraction without further purification.
- morphine is usually kept as an acid salt due to concerns regarding the stability of morphine in basic solutions. To test the stability of morphinate in basic aqueous solutions, morphinatc was analyzed by High Performance Liquid Chromatography (HPLC) and then allowed to stay overnight at room temperature. The morphinate was then reanalyzed by HPLC. No loss of morphine was found.
- the residue remaining after removing the alcohol is then extracted with a basic aqueous solution having a pH of at least 1 1.
- the basic aqueous solution is a solution of an alkali hydroxide such as sodium hydroxide or potassium hydroxide. Solutions of other bases may also be used. Maintaining the pH ofthe aqueous extract at this pFI and preferably within a relatively narrow preferred range allows high quality morphine to be obtained with good recovery. At lower pH values, greater amounts of morphine may be lost in the initial precipitate. At higher pH values, less impurities may be extracted into toluene. Maintaining the pH in the range of 11.5 to 11.9 is, therefore, preferred.
- the basic aqueous solution may optionally be filtered to remove any solid material remaining after the aqueous extraction step. Filtering the basic aqueous solution at this point removes insoluble non-morphine alkaloids. Any precipitate may be washed with -in additional quantity of the basic aqueous solution to ensure increased recovery of the morphine.
- the basic aqueous solution or filtrate if filtered, is then extracted with a substantially water-immiscible organic solvent to remove the remaining alkaloids from the basic aqueous filtrate.
- Suitable solvents include, but are not limited to, benzene, toluene, xylene, diethyl ether, and chloroform. Separation ofthe resulting aqueous and organic phases may be accomplished by techniques known in the art.
- non-morphine alkaloids are supposed to precipitate out of concentrated aqueous solutions at pH values around 1 1-12.
- the presence of concentrated morphinate ions may increase the solubility of the other alkaloids.
- substantial amounts of non- morphine alkaloids may remain in solution.
- Direct extraction of the basic aqueous solution or filtrate, if filtered, with a substantially water-immiscible solvent can remove those alkaloids, but may result in formation of an emulsion.
- the aqueous solution/filtrate may, before extraction with the substantially water-immiscible solvent, first be treated with a sufficient amount of an alkali metal salt or alkaline earth metal salt, for example 0.5 to 5 grams salt for each 5 grams of opium.
- Preferred salts are, for example, lithium chloride, lithium bromide, lithium acetate, sodium chloride, sodium bromide, sodium acetate, potassium chloride, potassium bromide, or potassium acetate.
- a preferred amount of the salt is 0.5 to 2 grams per 5 grams of opium.
- Sodium chloride and sodium acetate are preferred salts with sodium acetate being particularly preferred.
- the extract may then preferably filtered again to get rid of any gummy or other precipitate prior to extracting with a substantially water-immiscible solvent, such as benzene or toluene.
- the sequence of the morphine purification procedure may, however, affect the recovery of morphine. For example, if, to avoid emulsion formation upon extraction, a salt is added to the basic aqueous solution before it is filtered after the aqueous extraction step, as much as about 20% of the morphine may precipitate out along with the other alkaloids. Accordingly, the recovery of morphine will be substantially lower.
- a small amount, generally about 8%, of the morphine may be extracted into the solvent. This may be recovered by back extraction with additional basic solution, for instance, a sodium hydroxide solution. Any loss of mo ⁇ hine in the aqueous mother liquor, about 2%, may be recovered by additional extraction with the solvent.
- additional basic solution for instance, a sodium hydroxide solution.
- Any loss of mo ⁇ hine in the aqueous mother liquor, about 2%, may be recovered by additional extraction with the solvent.
- the use of toluene is preferred, particularly over benzene, in the process of the invention.
- Any alkaloids precipitated on a filter aid or paper in the process may be recovered by extraction with an alcohol, preferably methanol.
- the filter aid can be used again without further purification.
- the other opiate alkaloids that were extracted into the substantially water- immiscible solvent may be combined wilh the alkaloids which precipitated from the aqueous extract at pH 1 1.5 to 1 1.9 and further purified by other known methods.
- the pH of the basic aqueous solution/filtrate is adjusted to about 8.5 to 9.5 to precipitate the morphine.
- the pH is adjusted to 9 to 9.3 and more preferably to 9.1.
- the pH may be adjusted using an acid such as, for example, sulfuric acid, hydrochloric acid or acetic acid.
- a 50% acetic acid in water solution is used.
- the precipitated mo ⁇ hine may then be recovered using techniques known in the art such as filtration or decantation.
- the recovered morphine is preferably washed with water before drying.
- Figure 1 depicts a preferred process ofthe invention. The whole process, from extraction of opium to precipitation of purified mo ⁇ hine, can generally be completed in one day. This is much more efficient than other existing commercial purification methods.
- EXAMPLE 5 g of opium were cut into small pieces and extracted by reflux with 0.4 g of sodium hydroxide in 25 ml of methanol for 1 to 2 hrs. The methanol extract was then filtered to remove particulate materials. After addition of 1 g of filter aid to the methanol extract, which contained 465 to 485 mg of morphine, the methanol was removed under reduced pressure. The residue was then mixed with 5.5 ml of 1.0 N sodium hydroxide solution at 35 ° C for 10 min. and the pH adjusted to about 1 1.5 to 1 1.9 with 50% acetic acid in water. This aqueous extract was then filtered and the precipitate washed with 5.5 ml of 0.01 N sodium hydroxide solution.
- the combined aqueous filtrate was stirred with 0.5 g of sodium acetate for 10 minutes and filtered again.
- the fi I Irate was then extracted twice wilh 5 ml of toluene and Ihc pi I of the aqueous filtrate was then adjusted to pll 9.1 , with 50% acetic acid in water.
- the mixture was allowed to remain for a period of 6-10 hrs at room temperature for complete precipitation and was then filtered.
- This precipitate was washed with water and dried at room temperature.
- This final precipitate contained 400-426 mg of morphine, which represented a recovery of 86-88%) based upon the amount of mo ⁇ hine in the initial methanol extract.
- the purity of morphine following this procedure was 84% to 86% by weight.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU10815/97A AU1081597A (en) | 1995-11-21 | 1996-11-21 | Process for extracting and purifying morphine from opium |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US741895P | 1995-11-21 | 1995-11-21 | |
US60/007,418 | 1995-11-21 | ||
US08/753,061 | 1996-11-19 | ||
US08/753,061 US6054584A (en) | 1996-11-19 | 1996-11-19 | Process for extracting and purifying morphine from opium |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997019083A1 true WO1997019083A1 (en) | 1997-05-29 |
WO1997019083A9 WO1997019083A9 (en) | 1997-10-16 |
Family
ID=26676955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/018793 WO1997019083A1 (en) | 1995-11-21 | 1996-11-21 | Process for extracting and purifying morphine from opium |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1997019083A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102749402A (en) * | 2012-08-07 | 2012-10-24 | 公安部禁毒情报技术中心 | Preparation method of morphine hydrochloride standard substance |
CN110713494A (en) * | 2019-09-20 | 2020-01-21 | 甘肃省药物碱厂 | Treatment method for removing impurities from high-purity morphine |
-
1996
- 1996-11-21 WO PCT/US1996/018793 patent/WO1997019083A1/en active Application Filing
Non-Patent Citations (1)
Title |
---|
CHEMICAL ABSTRACTS, vol. 98, no. 2, 10 January 1983, Columbus, Ohio, US; abstract no. 8160w, TROJANEK, JAN ET AL: "Extraction of opium alkaloids." XP002025579 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102749402A (en) * | 2012-08-07 | 2012-10-24 | 公安部禁毒情报技术中心 | Preparation method of morphine hydrochloride standard substance |
CN110713494A (en) * | 2019-09-20 | 2020-01-21 | 甘肃省药物碱厂 | Treatment method for removing impurities from high-purity morphine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6054584A (en) | Process for extracting and purifying morphine from opium | |
US4886889A (en) | Process for recovery of an amino acid from aqueous mixtures thereof | |
ZA200601864B (en) | Process for purifying mesotrione | |
US20080262223A1 (en) | Isolation of Galanthamine From Biological Material | |
DE69818105T2 (en) | METHOD FOR PRODUCING BETA-HALOGEN-ALPHA-AMINO-CARBONIC ACIDS, PHENYLCYSTEINE DERIVATIVES AND THEIR INTERMEDIATES | |
WO1997019083A1 (en) | Process for extracting and purifying morphine from opium | |
WO1997019083A9 (en) | Process for extracting and purifying morphine from opium | |
CA2537986C (en) | Process for purifying mesotrione | |
CN101336228B (en) | Process for the manufacture of iohexol | |
CA2005921A1 (en) | Process for recovering lactic acid from solutions which contain it | |
EP0707589B1 (en) | Process for the extraction and purification of alkaloids | |
US6949645B1 (en) | Process for the production of opiates | |
WO2025035570A1 (en) | Process for recovering pyridine or pyridine derivatives from waste residue produced during synthesis of hexachlorocyclotriphosphazene | |
EP0174142B1 (en) | Recovery of squaric acid | |
KR910009943A (en) | Method for recovering gallium from basic solution containing gallium | |
US6676976B2 (en) | Process for the production of vasicine | |
US4418016A (en) | Method for recovering omega-amino-dodecanoic acid from crystallization mother liquors | |
WO2001027134A1 (en) | Process for extracting estrogens from pregnant mare urine (pmu) | |
WO2005082910A1 (en) | Process for isolation of ergot alkaloids from ergot | |
JPH02149549A (en) | Method of extracting amino acid from aqueous amino acid solution | |
DE2532308C3 (en) | Process for separating serotonin from coffee wax | |
EP0970941A4 (en) | APPARATUS AND METHOD FOR RECOVERING SORBIC ACID | |
KR100600520B1 (en) | Method of manufacturing solenesol | |
EP1487837B1 (en) | An improved process for the production of vasicine | |
US4070358A (en) | Process for the preparation of diindole alkaloids or of the acid addition salts thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1-7, DESCRIPTION, PAGES 8-10, CLAIMS, AND PAGE 1/1, DRAWINGS, REPLACED BY NEW PAGES BEARING THE SAME NUMBER; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT.BUL.23/97 UNDER INID (30) "PRIORITY DATA", REPLACE "NOT FURNISHED" BY "08/753061" |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97519930 Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |